The Morgantown community was out in force this Wednesday evening at various local restaurants to show support for Dine Out for Breast Reconstruction Awareness (BRA) Day.
The purpose of BRA Day was to raise awareness of breast reconstruction options available to women following breast cancer surgery. The event was spearheaded by Cristiane Ueno, MD, of WVU Medicine’s Division of Plastic, Reconstructive and Hand Surgery. WVU Medicine, in conjunction with the Morgantown Area Chamber of Commerce, encouraged local restaurants to participate in BRA Day by donating a percentage of their total receipts to help create a fund at WVU for patient education and assistance to uninsured and underinsured women seeking breast reconstruction. Eighty percent of the proceeds raised this week will stay in the WVU fund to benefit women in West Virginia, and 20 percent will be donated directly to The Plastic Surgery Foundation’s Breast Reconstruction Awareness Fund. “We don’t know how much money we raised yet, but the turnout was great,” Dr. Ueno said.
Archie’s Lakehouse, which donated 50% of total sales, was packed; the WVU Medicine operating room staff was among the huge crowd at Applebee’s; and the WVU football team dined out at BW3.
“As Betty Puskar said recently, Morgantown is a very participative community, and it is great that we can engage the community to work together for such a great cause,” Ueno said.
The WVU Cancer Institute is the first institution in the United States to offer intraoperative radiation therapy (IORT) to treat glioblastoma.
Several events at this year’s West Virginia Writers’ Workshop, July 20-23 at WVU, are focused on the role of writing and storytelling in health. Presenters include narrative medicine faculty from several campuses across the U.S., along with the leaders of an expressive writing program for patients at the WVU Cancer Institute. Health sciences faculty, staff and students are invited to participate in some or all of the Workshop.
WVU cancer researcher participates in study that shows promising treatments for certain patients with advanced colorectal cancer
A group of cancer researchers, including Richard Goldberg, M.D., director of the WVU Cancer Institute, released a study today in the Journal of the American Medical Association comparing the results of combinations of chemotherapy delivered with targeted therapy drugs in the treatment of people with advanced colorectal cancer who had not received prior drug treatment for their advanced disease.